
Physiomics Plc – LSE:PYC.L
Physiomics stock price today
Physiomics stock price monthly change
Physiomics stock price quarterly change
Physiomics stock price yearly change
Physiomics key metrics
Market Cap | 1.45M |
Enterprise value | N/A |
P/E | -29.57 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 2.38 |
Price/Book | 2.50 |
PEG ratio | -2.21 |
EPS | N/A |
Revenue | 1.31M |
EBITDA | -1.01M |
Income | -826.08K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -8.06% |
Oper. margin | -16.82% |
Gross margin | 0% |
EBIT margin | -16.82% |
EBITDA margin | -77.51% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePhysiomics stock price history
Physiomics stock forecast
Physiomics financial statements
Jun 2021 | 339.31K | -142.82K | -42.09% |
---|---|---|---|
Dec 2022 | 338K | -232K | -68.64% |
Jun 2023 | 259.35K | -245.25K | -94.56% |
Dec 2023 | 374K | -206K | -55.08% |
Jun 2021 | 1323284 | 157.57K | 11.91% |
---|---|---|---|
Dec 2021 | 1299000 | 219K | 16.86% |
Dec 2022 | 961000 | 199K | 20.71% |
Dec 2023 | 793000 | 121K | 15.26% |
Dec 2021 | -242K | -7K | 0 |
---|---|---|---|
Dec 2022 | -186K | -4K | 0 |
Jun 2023 | -78.86K | -2.21K | 0 |
Dec 2023 | -351K | -1K | 338K |
Physiomics alternative data
Aug 2023 | 8 |
---|---|
Sep 2023 | 8 |
Oct 2023 | 8 |
Nov 2023 | 10 |
Dec 2023 | 10 |
Jan 2024 | 10 |
Feb 2024 | 10 |
Mar 2024 | 10 |
Apr 2024 | 10 |
May 2024 | 10 |
Jun 2024 | 10 |
Jul 2024 | 10 |
Physiomics other data
Insider | Compensation |
---|---|
Dr. James Simon Millen (1969) Chief Executive Officer & Director | $146,080 |
-
What's the price of Physiomics stock today?
One share of Physiomics stock can currently be purchased for approximately $6.3.
-
When is Physiomics's next earnings date?
Unfortunately, Physiomics's (PYC.L) next earnings date is currently unknown.
-
Does Physiomics pay dividends?
No, Physiomics does not pay dividends.
-
How much money does Physiomics make?
Physiomics has a market capitalization of 1.45M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 34.57% to 543.25K US dollars.
-
What is Physiomics's stock symbol?
Physiomics Plc is traded on the LSE under the ticker symbol "PYC.L".
-
What is Physiomics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Physiomics?
Shares of Physiomics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Physiomics's key executives?
Physiomics's management team includes the following people:
- Dr. James Simon Millen Chief Executive Officer & Director(age: 56, pay: $146,080)
-
How many employees does Physiomics have?
As Jul 2024, Physiomics employs 10 workers.
-
When Physiomics went public?
Physiomics Plc is publicly traded company for more then 20 years since IPO on 20 Dec 2004.
-
What is Physiomics's official website?
The official website for Physiomics is physiomics.co.uk.
-
How can i contact Physiomics?
Physiomics can be reached via phone at +44 1865 784980.
Physiomics company profile:

Physiomics Plc
physiomics.co.ukLSE
11
Biotechnology
Healthcare
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.
Oxford, OX4 4GA
:
ISIN: GB00BDR6W943
CUSIP: G7097C113